Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Biogen Inc shares valued at $300,105 were sold by Izzar Rachid on Jul 08 ’25. At $135.00 per share, Izzar Rachid sold 2,223 shares. The insider’s holdings dropped to 6,330 shares worth approximately $0.81 million following the completion of this transaction.
Also, Izzar Rachid purchased 2,223 shares, netting a total of over 300,105 in proceeds.
Before that, Singhal Priya had sold 3,806 shares from its account. In a trade valued at $480,508, the Head of Development traded Biogen Inc shares for $126.25 each. Upon closing the transaction, the insider’s holdings decreased to 3,806 shares, worth approximately $0.7 million.
As published in a research note from HSBC Securities on April 28, 2025, Biogen Inc [BIIB] has been rated down from a Buy to a Hold and the price target has been revised to $118. Analysts at Argus downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in early April. As of February 11, 2025, Bernstein has initiated its “Mkt perform” rating for BIIB. Earlier on January 02, 2025, Piper Sandler downgraded its rating. Their new recommendation was “a Neutral” for BIIB stock which previously was a “an Overweight”.
Analyzing BIIB Stock Performance
On last trading session,, Biogen Inc [NASDAQ: BIIB] rose 0.18% to $128.69. The stock’s lowest price that day was $127.325, but it reached a high of $129.205 in the same session. During the last five days, there has been a drop of approximately -4.91%. Over the course of the year, Biogen Inc shares have dropped approximately -41.92%.
Support And Resistance Levels for Biogen Inc (BIIB)
RSI (Relative Strength Index) is 47.36 on the 14-day chart, showing neutral technical sentiment.
Is Biogen Inc subject to short interest?
Stocks of Biogen Inc saw a sharp rise in short interest on 2025-06-13 jumping by 49637.0 shares to 3.39 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 3.34 million shares. A jump of 1.46% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.14 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.14.
Which companies own the most shares of Biogen Inc (BIIB)?
In terms of Biogen Inc share price expectations, FactSet research, analysts set an average price target of 196 in the next 12 months, up nearly 52.58% from the previous closing price of $128.46. Analysts anticipate Biogen Inc stock to reach 270 by 2025, with the lowest price target being 118. In spite of this, 32 analysts ranked Biogen Inc stock as Buy at the end of 2025. On December 20, 2024, BMO Capital Markets assigned a price target of “a Market perform” to the stock and downgraded coverage with a $164.
